Cargando…

Editorial: Translational Research in Thyroid Cancer

Detalles Bibliográficos
Autores principales:	Vasko, Vasyl, Kebebew, Electron, Cheng, Sheue-yann, Jensen, Kirk Ernest
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174598/ https://www.ncbi.nlm.nih.gov/pubmed/32351455 http://dx.doi.org/10.3389/fendo.2020.00224

Ejemplares similares

Editorial: Translational research in thyroid cancer, Volume II
por: Cheng, Sheue-yann, et al.
Publicado: (2023)

PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer
por: Kari, Suresh, et al.
Publicado: (2019)

Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)
por: Thakur, Shilpa, et al.
Publicado: (2019)

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study
por: Aswath, Kshama, et al.
Publicado: (2021)

MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
por: Xiong, Yin, et al.
Publicado: (2014)

Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
por: Zhang, Lisa, et al.
Publicado: (2016)

Biomarkers in Thyroid Tumor Research: New Diagnostic Tools and Potential Targets of Molecular-Based Therapy
por: Gimm, Oliver, et al.
Publicado: (2011)

miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2015)

Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment
por: Vasko, Vasyl
Publicado: (2023)

MON-556 Sex-Bias in Clinicopathological Presentation of Patients with Differentiated Thyroid Cancer
por: Shobab, Leila, et al.
Publicado: (2019)

Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2021)

Editorial: Thyroid hormone actions in cancer
por: Cayrol, Florencia, et al.
Publicado: (2023)

SAT-568 Glutamine Metabolism Is a New Potential Therapeutic Target in Aggressive Thyroid Cancer
por: Patel, Dhaval, et al.
Publicado: (2019)

Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm
por: Romanelli, Kristen, et al.
Publicado: (2021)

Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research
por: Wu, Wan-Chen, et al.
Publicado: (2021)

Editorial: Targeted therapy in advanced thyroid cancer
por: Boucai, Laura
Publicado: (2022)

Cell non-autonomous effect of hepatic growth differentiation factor 15 on the thyroid gland
por: Jeong, Seonhyang, et al.
Publicado: (2022)

Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells
por: Bikas, Athanasios, et al.
Publicado: (2019)

Editorial: Non Genomic Actions of Thyroid Hormones in Cancer
por: Davis, Paul J., et al.
Publicado: (2019)

MON-563 Quantitative Assessment Of BRAF Mutations In Thyroid Cancer Using Droplet Digital PCR.
por: Ylli, Dorina, et al.
Publicado: (2019)

Editorial: Rising stars in translational endocrinology
por: Kasuki, Leandro
Publicado: (2023)

Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
por: Zhu, Xuguang, et al.
Publicado: (2017)

Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
por: Malaguarnera, Roberta, et al.
Publicado: (2018)

Editorial: Double-edged swords: Important factors connecting metabolic disorders and cancer development – from basic research to translational applications
por: Kung, Che-Pei, et al.
Publicado: (2023)

Editorial: “Homeostasis and Allostasis of Thyroid Function”
por: Dietrich, Johannes W., et al.
Publicado: (2018)

Editorial: The Unusual Presentation of Thyroid Disorders
por: Papi, Giampaolo, et al.
Publicado: (2019)

Editorial: Thyroid hormones and cardiac arrhythmia
por: Dietrich, Johannes W., et al.
Publicado: (2022)

Editorial: Environmental exposures and thyroid health
por: van Gerwen, Maaike, et al.
Publicado: (2023)

Editorial: Thyroid nodules and tumors in childhood
por: de Sanctis, Luisa, et al.
Publicado: (2023)

Editorial: Personalized Medicine in Cancer Research
por: Werner, Haim, et al.
Publicado: (2018)

Targeting transcriptional regulators for treatment of anaplastic thyroid cancer
por: Lee, Woo Kyung, et al.
Publicado: (2021)

Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer
por: Fozzatti, Laura, et al.
Publicado: (2020)

A Preliminary Study of Quantitative Ultrasound for Cancer-Risk Assessment of Thyroid Nodules
por: Goundan, Poorani N., et al.
Publicado: (2021)

MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2011)

Editorial: “Thyroid Hormone in Brain and Brain Cells”
por: Flamant, Frédéric, et al.
Publicado: (2015)

Editorial: The Role of Thyroid Hormones in Vertebrate Development
por: Sachs, Laurent M., et al.
Publicado: (2019)

Editorial: The role of genetic alterations in thyroid carcinoma
por: Feldkamp, Joachim
Publicado: (2022)

Editorial: New insights in thyroid and Covid-19
por: Sgarbi, Jose Augusto, et al.
Publicado: (2022)

Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2017)

Editorial: Novel Imaging Techniques in the Management of Thyroid Nodules and Autoimmune Thyroid Disease
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cnr126qoml9ud92lnsi3v2vu2j